Can These Beaten Down Stocks Bounce Back?
NIKE (NKE) and Intuitive Surgical (ISRG) shares have underperformed in 2026. NIKE reported Q4 adjusted EPS of $0.20, beating estimates, but revenue declined 1%. ISRG's Q2 adjusted EPS rose 27.9%, topping estimates, with revenue up 18.5%. Both face challenges, with NIKE struggling with sales declines and ISRG dealing with valuation concerns and slower procedure growth.
How this was made
The 30-second read
Why it matters
Both firms show mixed signals; earnings beats provide short‑term support, but revenue weakness and high valuations limit upside.
Market read
Earnings updates for two large‑cap stocks with recent underperformance; investors may reassess positions based on revenue trends.
What to watch
Nike's inventory management and ISRG's cost structure improvements could mitigate current headwinds.
Background
The article reviews recent earnings performance of two beaten‑down stocks, Nike and Intuitive Surgical, highlighting both positive earnings surprises and ongoing revenue challenges.
Ticker impact
Nike reported Q4 adjusted EPS of $0.20 beating estimates but revenue fell 1% YoY to $11B, with direct sales down 7% and Greater China revenue down 17%.
Potential further downside or flat trading as investors weigh weak revenue against EPS beat.
Revenue miss and soft direct sales outweigh EPS beat, likely limiting upside.
Intuitive Surgical posted Q2 adjusted EPS of $2.80 (+27.9% YoY) beating estimates, revenue up 18.5% to $2.9B, but da Vinci procedure growth slowed and shares fell over 30% YTD.
Shares may stabilize with modest upside if growth picks up, but valuation compression limits rally.
Earnings beat supports price, yet slowing growth and high multiples keep risk elevated.
Market effects
Both companies highlight challenges in consumer discretionary and healthcare equipment sectors amid valuation pressures.
Nike's China weakness may affect broader apparel exposure; ISRG's U.S. procedure slowdown signals caution for med‑tech.
Limited, confined to sector‑specific sentiment.
Counterpoint
Nike's turnaround could accelerate if digital initiatives improve; ISRG may benefit from long‑term surgical adoption despite short‑term slowdown.
Key entities
- CompanyNike, Inc.
Apparel and footwear maker reporting Q4 results.
- CompanyIntuitive Surgical, Inc.
Medical device maker reporting Q2 results.
